Military medicine
Semaglutide Decreases Risk of Non-Arteritic Anterior Ischemic Optic Neuroapthy in Type 2 Diabetic Patients.
Rachel A Lieberman, Jessica Korona-Bailey, Amanda Banaag, Barbara Furhman, Richele Corrado, Tracey Perez Koehlmoos
Published: 202510.1093/milmed/usaf522
Abstract
INTRODUCTION: Although the association between semaglutide use for diabetes or obesity and non-arteritic ischemic optic neuropathy (NAION) has been investigated, the relative risk has not been established in large, racially diverse populations. Given…
Preview only. Read the full abstract at the source